Cargando…

A reverse translational pharmacological approach to understand the underlying mechanisms of the reported association between hydrochlorothiazide and non-melanoma skin cancer

Detalles Bibliográficos
Autores principales:	Bigagli, Elisabetta, Mugelli, Alessandro, Mancia, Giuseppe
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Lippincott Williams & Wilkins 2022
Materias:	Editorial
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9451910/ https://www.ncbi.nlm.nih.gov/pubmed/35822584 http://dx.doi.org/10.1097/HJH.0000000000003167

Ejemplares similares

Hydrochlorothiazide Use and Risk of Nonmelanoma Skin Cancers: A Biological Plausibility Study
por: Bigagli, Elisabetta, et al.
Publicado: (2021)

Reverse Translational Pharmacology Research Is Driven by Big Data
por: Li, Lang
Publicado: (2018)

Association of Hydrochlorothiazide Use and Risk of Malignant Melanoma
por: Pottegård, Anton, et al.
Publicado: (2018)

Hydrochlorothiazide: A savior to the heart or a foe to the skin?
por: Kumar, Ayush, et al.
Publicado: (2022)

Telmisartan/hydrochlorothiazide: Nevus-associated cutaneous melanoma: case report
Publicado: (2021)

Re-engineering pharmacology teaching and research: Can we adopt translational approach?
por: Kulkarni, S. K.
Publicado: (2010)

Hydrochlorothiazide and Prevention of Kidney Stone Recurrence: A #NephJC Editorial on the NOSTONE Trial
por: Pasilan, Renz Michael, et al.
Publicado: (2023)

Effects of Telmisartan with Hydrochlorothiazide versus Valsartan with Hydrochlorothiazide in Patients with Moderate-to-Severe Hypertension
por: Marfatia, Ravi, et al.
Publicado: (2012)

It's Time to Reverse our Thinking: The Reverse Translation Research Paradigm
por: Shakhnovich, Valentina
Publicado: (2018)

Global HIV/AIDS Clinical and Translational Pharmacology
por: Morse, Gene D., et al.
Publicado: (2012)

Telmisartan/hydrochlorothiazide-induced hepatotoxicity
por: Lorena, Marco, et al.
Publicado: (2015)

Hydrochlorothiazide: Hypocalcaemia: case report
Publicado: (2020)

Skin check partner assistance for melanoma skin self-examination by at-risk patients: it takes two to identify melanomas
por: Robinson, June K
Publicado: (2020)

Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case–control study
por: Pottegård, Anton, et al.
Publicado: (2019)

Advances in Understanding Spontaneously Occurring Melanoma in Animals
por: Blacklock, Kelly L., et al.
Publicado: (2023)

Telmisartan/hydrochlorothiazide versus valsartan/hydrochlorothiazide in obese hypertensive patients with type 2 diabetes: the SMOOTH study
por: Sharma, Arya M, et al.
Publicado: (2007)

Design and optimization of bilayered tablet of Hydrochlorothiazide using the Quality-by-Design approach
por: Dholariya, Yatin N, et al.
Publicado: (2014)

Translational and Clinical Pharmacology: Note from the new Editor-in-Chief
por: Shin, Sang-Goo
Publicado: (2019)

Arterial stiffness and COVID‐19: A bidirectional cause‐effect relationship
por: Saeed, Sahrai, et al.
Publicado: (2021)

Treatment of Hypertension with Combination of Lisinopril/Hydrochlorothiazide
por: Sukalo, Aziz, et al.
Publicado: (2016)

Chlorthalidone, not hydrochlorothiazide, is the right diuretic for comparison
por: Mehta, Ravi Tejraj, et al.
Publicado: (2018)

Preparation of Hydrochlorothiazide Nanoparticles for Solubility Enhancement †
por: Vaculikova, Eliska, et al.
Publicado: (2016)

Hydrochlorothiazide: Hypokalaemia: 2 case reports
Publicado: (2022)

Comparative antiplatelet effects of chlorthalidone and hydrochlorothiazide
por: Bashir, Khalid, et al.
Publicado: (2022)

Management of patients with melanoma and non-melanoma skin cancers in the coronavirus disease 2019 era
por: Conforti, Claudio, et al.
Publicado: (2020)

Comments on “Use of hydrochlorothiazide and risk of skin cancer: a nationwide Taiwanese case-control study”
por: Taherifard, Erfan
Publicado: (2020)

Hydrochlorothiazide increases risk of nonmelanoma skin cancer in an elderly Japanese cohort with hypertension: The Shizuoka study
por: Hashizume, Hideo, et al.
Publicado: (2023)

Acute hepatocellular and cholestatic injury during therapy with hydrochlorothiazide - clinicohistopathologic findings: a case report
por: Taglietti, Fabrizio, et al.
Publicado: (2010)

Is the fixed-dose combination of telmisartan and hydrochlorothiazide a good approach to treat hypertension?
por: Maillard, Marc P, et al.
Publicado: (2007)

Efficacy of Aliskiren/Hydrochlorothiazide Combination for the Treatment of Hypertension: A Meta-Analytical Approach
por: Morgado, Manuel P, et al.
Publicado: (2011)

Zofenopril Plus Hydrochlorothiazide and Irbesartan Plus Hydrochlorothiazide in Previously Treated and Uncontrolled Diabetic and Non-diabetic Essential Hypertensive Patients
por: Agabiti-Rosei, Enrico, et al.
Publicado: (2014)

Comparative Efficacy of Irbesartan/ Hydrochlorothiazide and Valsartan/Hydrochlorothiazide Combination in Lowering Blood Pressure: A Retrospective Observational Study in Oman
por: Al Balushi, K.A., et al.
Publicado: (2013)

From Molecule to Patient: Building Bridges Not Walls with Clinical Pharmacology and Translational Medicine
por: Uemura, Naoto
Publicado: (2019)

A decade plus of translation: what do we understand?
por: Wang, Xiangdong, et al.
Publicado: (2012)

Recent Progress in the Diagnosis and Treatment of Melanoma and Other Skin Cancers
por: Pawlik, Laura, et al.
Publicado: (2023)

Olmesartan medoxomil combined with hydrochlorothiazide for the treatment of hypertension
por: Greathouse, Mark
Publicado: (2006)

Milk Alkali and Hydrochlorothiazide: A Case Report
por: Parvez, Babar, et al.
Publicado: (2011)

Fixed combination of irbesartan and hydrochlorothiazide in the management of hypertension
por: Bramlage, Peter
Publicado: (2009)

Spectrophotometric Estimation of Olmesartan Medoxomil and Hydrochlorothiazide in Tablet
por: Rote, A. R., et al.
Publicado: (2010)

The metabolic cost of lowering blood pressure with hydrochlorothiazide
por: Price, Angela L, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_miq26s7n50bedi493am7vq8pfq